QUINIDINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Quinidine Sulfate patents expire, and what generic alternatives are available?
Quinidine Sulfate is a drug marketed by Lilly, Cosette, Barr, Chartwell Molecular, Chartwell Rx, Contract Pharmacal, Cycle, Dava Pharms Inc, Elkins Sinn, Epic Pharma Llc, Everylife, Halsey, Hikma, Impax Labs, Ivax Sub Teva Pharms, King Pharms, Kv Pharm, Lederle, Perrigo, Pharmavite, Purepac Pharm, Sandoz, Scherer Labs, Sun Pharm Industries, Superpharm, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage Pharms, Warner Chilcott, Watson Labs, and Whiteworth Town Plsn. and is included in forty NDAs.
The generic ingredient in QUINIDINE SULFATE is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinidine Sulfate
A generic version of QUINIDINE SULFATE was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINIDINE SULFATE?
- What are the global sales for QUINIDINE SULFATE?
- What is Average Wholesale Price for QUINIDINE SULFATE?
Summary for QUINIDINE SULFATE
| US Patents: | 0 |
| Applicants: | 32 |
| NDAs: | 40 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 214 |
| Clinical Trials: | 21 |
| Patent Applications: | 3,195 |
| Drug Prices: | Drug price information for QUINIDINE SULFATE |
| DailyMed Link: | QUINIDINE SULFATE at DailyMed |
Recent Clinical Trials for QUINIDINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| ALS Association | Phase 1/Phase 2 |
| University of Florida | Phase 1/Phase 2 |
| Holy Cross Hospital, Florida | Phase 1/Phase 2 |
Pharmacology for QUINIDINE SULFATE
| Drug Class | Antiarrhythmic Cytochrome P450 2D6 Inhibitor |
| Mechanism of Action | Cytochrome P450 2D6 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for QUINIDINE SULFATE
US Patents and Regulatory Information for QUINIDINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Whiteworth Town Plsn | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 085444-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Usl Pharma | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 087837-001 | Apr 14, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 081029-001 | Apr 14, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharm Intl | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 083393-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 081030-001 | Apr 14, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | QUINIDINE SULFATE | quinidine sulfate | CAPSULE;ORAL | 085103-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms | QUINIDINE SULFATE | quinidine sulfate | TABLET;ORAL | 085175-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
